Clinical Trials Logo

Cocaine-Related Disorders clinical trials

View clinical trials related to Cocaine-Related Disorders.

Filter by:

NCT ID: NCT00000342 Completed - Clinical trials for Cocaine-Related Disorders

Risperidone for the Treatment of Cocaine Dependence - 7

Start date: July 1996
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate clinical safety and pharmacological efficacy in the treatment of cocaine dependence, to evaluate impact of treatment on craving, and to correlate evidence of baseline neurotoxic damage of cocaine with treatment outcome and clinical side-effects.

NCT ID: NCT00000337 Completed - Clinical trials for Cocaine-Related Disorders

Infusion Laboratory: Protocol 1 - Selegeline - 2

Start date: November 1994
Phase: Phase 1
Study type: Interventional

The purpose of this study is to determine the effects of selegiline on the subjective and physiological effects of cocaine challenge in chronic crack abusers, and to evaluate clinical safety issues pertaining to selegeline, to cocaine and their interaction in a chronic crack dependent population.

NCT ID: NCT00000336 Completed - Clinical trials for Cocaine-Related Disorders

Selegiline in Outpatient Treatment for Cocaine Dependence - 1

Start date: January 1995
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the efficacy and clinical safety of selegiline in the treatment of cocaine dependence and to assess neurotoxicity (Magnetic Resonance Imaging, MRI) post-hoc as a possible variable for future stratification in clinical trials.

NCT ID: NCT00000333 Completed - Clinical trials for Cocaine-Related Disorders

Evaluation of Benztropine for Cocaine Craving - 2

Start date: May 2001
Phase: Phase 2
Study type: Interventional

The purpose of this study is to compare the efficacy of benztropine (or DA reuptake inhibitor) with atropine and placebo in affecting stimulated craving to cocaine cues.

NCT ID: NCT00000332 Completed - Clinical trials for Cocaine-Related Disorders

High Dose Nimodipine Treatment Adjunct - 1

Start date: May 1998
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine if nimodipine is more effective than placebo in reducing stimulated craving for cocaine in cocaine dependent individuals denied access to cocaine in inpatient unit.

NCT ID: NCT00000325 Completed - Clinical trials for Cocaine-Related Disorders

Psychostimulant Abuse - Novel Treatment Approaches - 1

Start date: n/a
Phase: Phase 1
Study type: Interventional

To determine if acute assessments of profasi and factrel affect plasma cocaine levels and cocaine-induced behavioral changes in men.

NCT ID: NCT00000324 Completed - Clinical trials for Cocaine-Related Disorders

Tryptophan and Behavior Therapy for Cocaine Abuse - 1

Start date: March 1997
Phase: Phase 2
Study type: Interventional

The purpose of this study is to assess the efficacy of tryptophan vs. placebo, and voucher payments vs. a control condition, in the treatment of cocaine dependence.

NCT ID: NCT00000323 Completed - Clinical trials for Cocaine-Related Disorders

Therapeutic Potential of Kappa-Opioids Against Cocaine - 1

Start date: July 1996
Phase: Phase 1
Study type: Observational

The purpose of this study is to characterize the effects of enadoline compared to hydromorphone and butorphanol.

NCT ID: NCT00000317 Completed - Clinical trials for Substance-Related Disorders

Early Phase II Trials for Cocaine Medication Development - 1

Start date: August 1996
Phase: Phase 2
Study type: Interventional

The purpose of this study is to develop models for early Phase II testing of potential medications for cocaine dependence: amoxapine, risperidone and other agents. The study was a controlled pilot trial of risperidone in opiate-dependent patients on methadone maintenance. The study explored whether risperidone reduced cocaine use, cocaine craving, and cocaine subjective effects in patients on methadone maintenance who abused cocaine and whether it had an acceptable side effect profile. This

NCT ID: NCT00000316 Completed - Clinical trials for Cocaine-Related Disorders

Human Dopamine Transported Imaging in Cocaine Abuse: 2 - 2

Start date: August 1996
Phase: Phase 1
Study type: Interventional

The purpose of this study is to determine the density of DA transporters during prolonged cocaine abuse and during withdrawal from cocaine use. This aim will test the hypothesis that DA transporters are altered by cocaine abuse and reestablished during withdrawal.